Related Experiment Video
Updated: Jun 15, 2026
11:06
Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Published on: May 20, 2015
PADI4 and tumourigenesis.
1Laboratory for Bio-Drugs of Ministry of Health, Provincial Laboratory for Modern Medicine and Technology of Shandong, Research Center for Medicinal Biotechnology, Shandong Academy of Medical Sciences, Jingshi Road, Shandong, PR China. changxt@126.com
Cancer Cell International
|March 13, 2010
Summary
The enzyme peptidylarginine deiminase 4 (PADI4) converts arginine to citrulline, a process implicated in cancer. High PADI4 expression in tumors and patient blood suggests its role in tumorigenesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Peptidylarginine deiminase 4 (PADI4) catalyzes the conversion of peptidylarginine to citrulline (citrullination).
- PADI4 is highly expressed in various malignant tumor tissues and in the blood of cancer patients.
- Citrullination of key proteins like histones and fibronectin is linked to cancer hallmarks such as abnormal apoptosis and cell proliferation.
Purpose of the Study:
- To investigate the role of PADI4 and its enzymatic activity in the context of malignant tumors.
- To explore the expression patterns of PADI4 in normal and tumor tissues, particularly in stem cells.
Main Methods:
- Analysis of PADI4 expression levels in tumor tissues and patient blood samples.
- Investigation of PADI4 expression in CD34+ stem cells from normal and tumor tissues.
- Review of literature on the functional consequences of protein citrullination in cancer.
Main Results:
- PADI4 exhibits high expression in multiple types of malignant tumors.
- Elevated PADI4 levels are detected in the blood of patients with certain cancers.
- PADI4 is present in CD34+ stem cells, with increased numbers observed in tumor tissues.
Conclusions:
- The findings indicate a significant association between PADI4 expression and malignant tumors.
- PADI4 may play a crucial role in the initiation and progression of cancer (tumorigenesis).
- Further research into PADI4's mechanisms in cancer is warranted.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...